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Cellular and Humoral Immune-Modulation of lntimal 
Thickening After Injury in Mice 
Honavan Li, Previn de Silva. Kuang-Yuh Chyu. Takeo Anazawa, Juliana Yano, Prediman 
K. Shah, Bojan Cercek, Paul C. Dimayuga, Cedars-Sinai Medical Center, Los Angeles, 
CA 
Background: We previously reported exaggerated intimal thickening after arterial injury 
in immune-deficient Rag-l KO mice compared to wild-type mice. We evaluated the effect 
of normalizing immune functions through adoptive transfer of normal splenocytes, on mti- 
mal thickening in Rag-l KO mice, which lack mature T and B cells. 
Methods: Injury in wild type (WT) mice, Rag-1 KO mice and Rag-l KO mice reconsti- 
tuted with whole splenocyte (Rag-l KO T/B) was induced at 25 weeks of age using a 
carotid arterial cuff. Splenocytes for adoptive transfer were isolated from age-matched 
WT donors and injected i.v. (4-6 x 10’ cells/mouse) into Rag-l KO mice 46 hours prior to 
injury. lntimal thickening was measured 21 days after cuffing. DNFB skin test and serum 
interferon-gamma (IFN) ELISA before injury verified T cell function. Serum IgG and IgM 
were measured by ELISA to confirm B cell function 21 days after cuffing. Splenocyte 
homing was verified using PCR. 
Results: Splenocyte transfer resulted in partial normalization of immune functions and 
reduced intimal thickening in Rag-l KO mice (Table). 
Rag-l KO T/B mice had positive DNFB skin test. PCR confirmed presence of transferred 
cells in the spleens of Rag-l KO T/B mice. 
Conclusion: Our results show that transferred splenocytes from immune-competent 
mice decrease intimal thickenmg after injury in immune deficient mice. These data sug 
gest that immune-modulation plays a significant role in intimal thickening after injury. 
Table: 
Presentation Hour: IO:00 a.m.-l 1:00 a.m. 
1080-l 20 Dietary Supplementation With a-Linolenic Acid 
Decreases the Levels of C-Reactive Protein, Serum A 
Amyloid, and Interleukin-6 in Dyslipidemic Patients 
Loukianos S. Rallidis , Georgios Paschos, Maria L. Papaioannou, Georgios K. Liakos, 
Aggeliki H. Velisswidou, Antonios Zampelas, Evangelos G. Papasteriadis, General 
Hospital of Nikea. Piraeus, Greece, Harokopio University, Greece 
Background: Inflammation plays an important role in the pathogenesis of coronary 
artery disease (CAD). We examined whether dietary supplementation with a plant n-3 
polyunsaturated fatty acid, a-linolenic acid (ALA, 16:3n-3), affects the levels of inflamma- 
tory markers in dyslipidaemic patients (pts). 
Methods: We recruited 76 male dyslipidaemic pts (mean age=51+8 years) following a 
typical Greek diet. They were randomly assigned either to 15 ml of linseed oil per day 
containing 7.59 of ALA (n=50) or to 15 ml of sunflower oil per day containing 7.5 g of 
linoleic acid [LA, 18:2n-61 (n=26). Dietary intervention lasted for 3 months. Blood lipids 
and C-reactive protein (CRP), serum amyloid A (SAA), and interleukin-6 (IL-6) levels 
were determined prior and after intervention. CRP and SAA were measured by 
nephelometry and IL-6 by immunoassay. 
Group fFN(~glmf) IgG f9M lntimal Area (mm? 
WT 2172156 1.76fl.25 1.69+0.12 10+3x 1o-3 n=l1 
Rag-l KO 6341’ 0.00’ 0.05+0.02’ 24+12x10-“n=14 
Rag-l KO T/B 111+3Q 1.52+0.06t 1.75+0.06? 15+9x 10 r1=,3 
IgG and IgM levels are expressed as densitometric units at OD 405nm 
‘~0.05 vs. ury: tp<o.O5 vs. Rag-l KO. 
1079-I 36 Regulation of Estrogen Receptor Subtypes on Vascular 
Cells 
Pedro Gsraldes Martin G. Sirois, Jean-Franqois Tanguay, Montreal Heart Institute, 
Montreal, PQ, Canada 
Background: Most of the effects of estrogen on the cardiovascular system are mediated 
via estrogen receptor alpha (ERa) and beta (ERP) expressed in vascular tissues. 
Recently, several studies have reported the expression of ER on the plasma membrane 
of vascular endothelial cells and smooth muscle cells. However, little is known regarding 
the distribution of each ER subtypes on these cells. Furthermore, few data exist concern- 
ing the effects of an acute or chronic treatment with 17.beta-estradiol (17PE) on the local- 
ization of each receptor. 
Methods: Porcine aortic endothelial cells (PAEC) and smooth muscle cells (PSMC) were 
treated with 17!3E (1O-9 to 1U’M) * selective antagonist (10.‘M). Analysis of each ER 
subtype was performed using confocal microscopy by dividing the area of pixels of each 
ER bv the total area of the cell. Proteins from the cell membrane and the cvtoolasm were 
separated to evaluate the presence of each ER by Western Blot analysis. 
Results: In PBS-treated PAEC. ERa subtvoe was observed on the olasma membrane 
and in the perinuclear region. In contrast, ERP was located only in the perinuclear region. 
Treatment of PAEC with 17!3E for 30 minutes increased the ERn and ERP labelling in the 
perinuclear region by up to 229% and 118%. respectively, as compared to PBS-treated 
cells. These effects were reversed by a pretreatment with selective antagonist prior to 
17PE. Stimulation with 17PE for 24 hours did not significantly change the baseline distri- 
bution. On PSMC. ERP subtype was observed in the perinuclear region and on the 
plasma membrane while ERa was only located in the perinuclear region. Treatment of 
PSMC with 17PE for 30 minutes, but not for 24 hours, significantly increased both ERa 
and ERP visualization by up to 131% and 161% respectively as compared to PBS- 
treated cells. Again, a pretreatment with a selective antagonist reversed these effects. 
Conclusion: A rapid treatment with 17PE regulates the localization of ERu and ERP on 
vascular cells. Our results suggest that 17QE induces a dense labelling of ER subtypes in 
the perinuclear region of PAEC and PSMC which appears to be transient. 
Results: Dietary supplementation with ALA decreased significantly CRP, SAA and IL-6 
levels as shown in the table. 
Variables Before supplementation with Aftersupplementatlon with p 
ALA ALA 
Total cholesterol 232+34 226-36 NS 
(mgidl) 
Triglycerides (mg/dl) 155+64 163*67 NS 
HDL cholesterol 42.7*10.4 41*10.2 0.005 
(mgidl) 
LDL cholesterol (mgl 154i37 
dl) 
152zt36 NS 
CRP (ms/l) 1.24 (0.72-3.7) 0.93 (0.56-1.6) 0.000 
6 
SAA (mg/l) 3.24 (2.3-5.3) 2.39 (1.7-3.9) 0.000 
1 
IL-6 (pg/ml) 2.16 (1.35-3.9) 1.7 (1.3-2.6) 0.01 
The median decrease of CRP was 36%, of SAA 23.1% and of IL-6 10.5%. The decrease 
of inflammatory markers was independent of lipid changes. Dietary supplementation with 
LA did not affect significantly the levels of lipids, CRP. SAA and IL-6. 
Conclusions: Dietary supplementation with ALA decreases significantly CRP, SAA and 
IL-6 levels in dyslipidaemic pts. This anti-inflammatory effect may provide a possible 
additional mechanism for the beneficial effect of plant n-3 polyunsaturated fatty acids in 
primary and secondary prevention of CAD. 
1080-121 Systemic Inflammation and Subclinical Carotid 
Atherosclerosis in Patients With Cardiac Syndrome X 
Nadia Mollichelli, Ramon Arroyo-Espliguero. Emmanouil Zouridakis, Valentin Newey, 
Dariush Nassiri, Juan C. Kaski. St. George’s Hospital Medical School, London, United 
Kingdom 
Background: Cardiac syndrome X patients have typlcal exertional chest pain and ST- 
segment depression despite normal coronary angiograms. Coronary risk factors and 
subangiographic atheroma have been reported and sugested to be responsible for 
endothelial dysfuntion in these patients. We assessed whether subclinical carotid artery 
disease is present in syndrome X patients and also investigated whether systemic 
inflammation correlates with subclinical carotid artery disease in cardiac syndrome X. 
Methods: We studied 30 consecutive patients with cardiac syndrome X (mean age 57+6 
years, 25 women) and 30 gender- age- and weight-matched healthy controls (mean age 
54~6 years, 25 women). Patients and subjects underwent high resolution ultrasonogra- 
phy examination to assess common carotid artery intima-media thickness (IMT), pres- 
ence of atherosclerotic plaques, arterial stiffness and distensibility. High sensitivity C- 
reactive protein (CRP) was measured in all patients and control subjects. Comparisons 
were performed by use of unpaired t-test and Chi-square test for continuous and categor- 
ical data, respectively. A P value co.05 was considered statistically significant. 
Results: Results are presented as mean *standard deviation and median [interquartile 
range] for normally and non-normally distributed data, respectively. Syndrome X patients 
had significantly htgher mean IMT values than controls (0.79iO.14 vs. 0.61*0.11 mm, 
P-zO.005). The prevalence of atherosclerotic plaques was higher in syndrome X patients 
than in control subjects (36.6% vs. lo%, P=O.Ol). Arterial stiffness was also significantly 
hioher in svndrome X oatients (13.5i5.6 vs. 10.9+3.9. P=O.O4). Hs-CRP levels were siq- 
” _  
nificantly higher in syndrome X patients (2.6 11.7.4.51 vs. 1.5 [0.7-2.7) mg/L. P=O.O2) aid 
correlated with carotid IMT (Soeanan’s rho=0.6: P=O.O03). 
Conclusions: Patients with syndrome X have both increased mean common carotid 
artery IMT and higher hs-CRP serum levels, suggesting the presence of a chronic inflam- 
mation background which lead to vascular dysfunction and atherogenesis in these 
patbents. These results may have pathophysiological and therapeutic impkcations. 
